Epitope Generation Gateway (EGG): A biological context-dependent approach to cancer vaccine development.

EGG identifies prioritized cancer vaccine epitopes from genomic variants that are linked to tumor fitness and key pathways in melanoma patients.

• Why it matters: Understanding which neoantigens are most relevant to tumor survival and immune escape can improve personalized vaccine development. This work addresses the need for tools that integrate biological context into epitope prioritization.
• What they did: The authors developed EGG, a containerized pipeline that combines variant calling, HLA typing, epitope prediction, and biological annotation, applying it to 30 melanoma patients to generate prioritized epitopes.
• The result: EGG produced candidate epitopes from genes important for tumor fitness and pathway involvement, demonstrating its ability to link epitope prediction with tumor systems biology and evolutionary considerations.